Paper25288
Long-term hypnotic efficacy and safety of triazolam and flurazepam.
Leibowitz M and 1 other. J Clin Pharmacol, 1978. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long-term hypnotic efficacy and safety of triazolam and flurazepam. Papers, record 25288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25288
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Flurazepam | Major topic |
| Hypnotics and Sedatives | Major topic |
| Triazolam | Major topic |
| Adult | |
| Ambulatory Care | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sleep | |
| Sleep Initiation and Maintenance Disorders | |
| Time Factors |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,947,394 | The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials. | Drugs | 2023 | https://conductscience.org/library/papers/36947394 | PubMed |
| 27,998,379 | Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. | J Clin Sleep Med | 2017 | https://conductscience.org/library/papers/27998379 | PubMed |
| 8,573,298 | An assessment of short-acting hypnotics. | Drug Saf | 1995 | https://conductscience.org/library/papers/8573298 | PubMed |
| 6,133,533 | Approaches in the evaluation of hypnotics: studies with triazolam. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6133533 | PubMed |
| 6,123,129 | Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6123129 | PubMed |
| 6,114,852 | Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. | Drugs | 1981 | https://conductscience.org/library/papers/6114852 | PubMed |
| 6,108,588 | The effects of flurazepam, lorazepam, and triazolam on sleep and memory. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6108588 | PubMed |
| 3,942,931 | Treatment of triazolam dependence with a tapering withdrawal regimen. | CMAJ | 1986 | https://conductscience.org/library/papers/3942931 | PubMed |
| 1,971,955 | Benzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood. | Psychopharmacology (Berl) | 1990 | https://conductscience.org/library/papers/1971955 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25288
GET https://conductscience.org/api/papers/v1/25288/authors